Share
Journal Information
Most often read
7478
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from VietnamHai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, ... Dinh-Toi Chu
Reumatol Clin. 2024;20:128-35
7478
3043
Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 casesPablo Arango Guerra, Santiago Monsalve Yepes, Andrés Chavarriaga Restrepo, Carlos Jaime Velasquez Franco
Reumatol Clin. 2024;20:218-22
3043
872
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practiceJordi Gratacós-Masmitja, Emma Beltrán Catalán, José Luis Álvarez Vega, Ana Urruticoechea-Arana, Concepción Fito, Francisco Maceiras, Joaquín María Belzunegui Otano, Julia Fernández Melón, ... on behalf of the PREVAIL team
Reumatol Clin. 2024;20:24-31
872
Full text access
Open Article
31
Usefulness of ultrasound in clinical decision-making in rheumatology clinical practice: A single-center longitudinal studyMarta Serrano-Warleta, Aliuska Palomeque-Vargas, Rosa Manzo, Boris Blanco-Cáceres, Mónica Vazquez-Díaz, Carlos Guillen-Astete
Reumatol Clin. 2024;20:147-9
31
12
Entities inside one another: VEXAS, a matryoshka-type diseaseSilvia Suárez-Díaz, Carmen Yllera-Gutiérrez, Claudia Morán-Castaño, Luis Caminal-Montero
Reumatol Clin. 2024;20:57-8
12
12
SER recommendations on treatment of refractory Behçet's syndromeClara Moriano Morales, Jenaro Graña Gil, Noé Brito García, José Luis Martín Varillas, Vanesa Calvo del Río, Patricia Moya Alvarado, Francisco Javier Narváez García, Gerard Espinosa, ... Julio Suárez Cuba
Reumatol Clin. 2024;20:204-17
12
8
VEXAS syndrome: Clinical manifestations, diagnosis, and treatmentMichelle Patricia Loeza-Uribe, Andrea Hinojosa-Azaola, Beatriz E. Sánchez-Hernández, José C. Crispín, Elia Apodaca-Chávez, Marcela A. Ferrada, Eduardo Martín-Nares
Reumatol Clin. 2024;20:47-56
8
7
Quality of life of patients with rheumatic diseasesLourdes Villalobos-Sánchez, Boris Blanco-Cáceres, Javier Bachiller-Corral, María Teresa Rodríguez-Serrano, Mónica Vázquez-Díaz, Pablo Lázaro y de Mercado
Reumatol Clin. 2024;20:59-66
7
7
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual riskCristiana Sieiro Santos, Maria Miguel Oliveira, Paulo Ney Solari, Pedro Mateus, Maria José Santos, Hector Corominas, Carolina Álvarez Castro, Elvira Díez Álvarez
Reumatol Clin. 2024;20:229-36
7
6
Effect of combined treatment with prednisone and methotrexate versus prednisone alone over laboratory parameters in giant cell arteritisInes Perez-Sancristobal, Paula Alvarez-Hernandez, Cristina Lajas-Petisco, Benjamin Fernandez-Gutierrez
Reumatol Clin. 2024;20:108-12
6
5
Termination of pregnancy in lupus nephritis: A bioethical analysis with the integrative methodTábata Cano-Gámez, Adriana Concepción Lobato-Belmonte, Ingris Peláez-Ballestas, Gabriel Medrano-Ramírez, Juan Carlos de León-Carbajal, Amaranta Manrique de Lara
Reumatol Clin. 2024;20:20-3
5
5
Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023Carlos Abud-Mendoza, Francisco Javier Aceves-Ávila, César Alejandro Arce-Salinas, José Álvarez Nemegyei, Leonor Barile-Fabris, Sergio Durán-Barragán, Diana Elsa Flores-Alvarado, Eufrates Hernández-Núñez, ... César Pacheco-Tena
Reumatol Clin. 2024;20:263-80
5
4
Comments about treatment of glucocorticoid-induced osteoporosisOsvaldo Daniel Messina
Reumatol Clin. 2024;20:113
4
4
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12Jose Antonio Pinto Tasende, Carlota Laura Iñiguez Ubiaga, Victor Eliseo Quevedo Vila, Luis Fernández Dominguez, Francisco Jose Maceiras Pan, Carlos García Porrúa
Reumatol Clin. 2024;20:80-3
4
3
The patient journey of fibromyalgia in Latin AmericaTeresa Otón, Osvaldo Daniel Messina, Daniel G. Fernández Ávila, Manuel Robles San Román, Darío Mata, Constanza Arguissain, Jorge Miguel Galindo Guzmán, Marina Pérez, ... Grupo Fibrojourney Latam
Reumatol Clin. 2024;20:32-42
3
3
Epidemiology of thromboembolic events in children and adolescents with antiphospholipid syndrome: A systematic review with meta-analysisMickael Essouma, Jan Rene Nkeck, Jean Jacques Noubiap
Reumatol Clin. 2024;20:155-61
3
3
Cost-effectiveness analysis of the diagnosis of temporal arteritisIsabel del Blanco Alonso, Álvaro Revilla Calavia, Laura Saiz-Viloria, Manuel Diez Martínez, Enrique San Norberto García, Carlos Vaquero Puerta
Reumatol Clin. 2024;20:181-6
3
3
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık
Reumatol Clin. 2024;20:123-7
3
2
Pigmentation disorders as a guide sign of autoimmune diseasesBeatriz Clemente Hernández, Itziar Muelas Rives, Adrián Ballano Ruiz, Tamara Gracia Cazaña
Reumatol Clin. 2024;20:45-6
2
2
An update on the study of synovial fluid in the geriatric patientJavier Fernández-Torres, Víctor Ilizaliturri-Sánchez, Karina Martínez-Flores, Carlos Alberto Lozada-Pérez, Rolando Espinosa-Morales, Yessica Zamudio-Cuevas
Reumatol Clin. 2024;20:193-8
2
Publish in
Reumatología Clínica
Free access articles
Reumatol Clin. 2024;20:24-31
Reumatol Clin. 2023;19:565-70
Reumatol Clin. 2023;19:319-27